Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina.
Dana-Farber Cancer Institute/Boston Children's Hospital, Boston, Massachusetts.
Cancer. 2021 May 1;127(9):1483-1494. doi: 10.1002/cncr.33389. Epub 2020 Dec 17.
Despite improvements in survival rates, cancer treatments have significant side effects that affect the quality of life of children and their families. When an ill child cannot self-report symptoms (eg, he or she is too ill), caregiver (parent) reporting becomes critical. This study evaluates the validity and reliability of the caregiver-reported Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (Ped-PRO-CTCAE [Caregiver]) measure.
A diverse sample of caregivers with children receiving treatment at 9 oncology centers completed the Ped-PRO-CTCAE [Caregiver] measure, the Patient-Reported Outcomes Measurement Information System (PROMIS ) Parent Proxy measures, the Lansky Play-Performance Scale (PPS), medication use questions, and Global Impressions of Change (GIC). Construct validity (including convergent, discriminant, and known groups validity and responsiveness over time) and reliability (stability) were examined.
A majority of the 473 caregivers were female (85%), non-Hispanic White (61%), and married (75%). Symptoms assessed with the Ped-PRO-CTCAE [Caregiver] and PROMIS Parent Proxy measures were strongly correlated (e.g., r for pain = 0.78; r for fatigue = 0.78; and r for depression = 0.83). Most of the Ped-PRO-CTCAE [Caregiver] item mean scores distinguished among PPS function levels and between children who did take medications for symptom control and children who did not. Changes in Ped-PRO-CTCAE [Caregiver] item mean scores were responsive to GIC over time. Test-retest evaluation found moderate to high agreement (57.8%-93.3%) over time.
This study found strong evidence for the convergent and discriminant validity, known groups validity, responsiveness, and stability of the Ped-PRO-CTCAE [Caregiver] measure in a large and diverse sample of caregivers. The caregiver perspective provides a valuable and unique insight into the experiences of children and adolescents undergoing cancer treatment.
Despite advances in cancer treatments, children and adolescents continue to suffer from treatment side effects, including pain, nausea, fatigue, and emotional distress, that can adversely affect quality of life for children and their families. Although it is best for children to report how they are feeling, there are times when a child may be too young or too ill to self-report. This study provides critical evidence for a new type of questionnaire that allows the caregiver or parent to report accurately what the child is experiencing. This measure can be used to improve adverse event reporting and child cancer care.
尽管生存率有所提高,但癌症治疗仍存在显著的副作用,影响儿童及其家庭的生活质量。当患病儿童无法自我报告症状(例如,他或她病得太重)时,照顾者(父母)的报告就变得至关重要。本研究评估了患儿报告的儿科患者报告结局版常见不良事件术语标准(Ped-PRO-CTCAE [照顾者])测量工具的效度和信度。
在 9 个肿瘤中心接受治疗的 473 名不同的照顾者完成了 Ped-PRO-CTCAE [照顾者]量表、患者报告结局测量信息系统(PROMIS)家长代理量表、兰斯基表演量表(PPS)、用药问题和总体印象变化(GIC)。考察了结构效度(包括聚合、区分和已知组有效性以及随时间的反应性)和信度(稳定性)。
大多数 473 名照顾者为女性(85%)、非西班牙裔白人(61%)和已婚(75%)。用 Ped-PRO-CTCAE [照顾者]和 PROMIS 家长代理量表评估的症状呈强相关性(例如,疼痛的 r 值为 0.78;疲劳的 r 值为 0.78;抑郁的 r 值为 0.83)。Ped-PRO-CTCAE [照顾者]量表的大多数项目平均分可区分 PPS 功能水平以及是否因症状控制而用药的儿童和未用药的儿童。随时间推移,Ped-PRO-CTCAE [照顾者]项目平均分的变化对 GIC 有反应。测试-重测评估发现随时间推移具有中等至高度的一致性(57.8%-93.3%)。
本研究在大量且多样化的照顾者样本中发现了 Ped-PRO-CTCAE [照顾者]测量工具具有较强的聚合和区分效度、已知组有效性、反应性和稳定性的有力证据。照顾者的观点为正在接受癌症治疗的儿童和青少年的体验提供了有价值且独特的见解。
尽管癌症治疗取得了进展,但儿童和青少年仍继续遭受治疗副作用的影响,包括疼痛、恶心、疲劳和情绪困扰,这些副作用会对儿童及其家庭的生活质量产生不利影响。尽管最好是让孩子报告自己的感受,但有时孩子可能太小或病得太重而无法自我报告。这项研究提供了一种新的调查问卷的重要证据,这种问卷允许照顾者或父母准确地报告孩子的体验。这种测量方法可用于改善不良事件报告和儿童癌症护理。
在 9 个肿瘤中心接受治疗的 473 名不同的照顾者完成了患者报告的儿科结局版常见不良事件术语标准(Ped-PRO-CTCAE [照顾者])量表、患者报告结局测量信息系统(PROMIS)家长代理量表、兰斯基表演量表(PPS)、用药问题和总体印象变化(GIC)。考察了结构效度(包括聚合、区分和已知组有效性以及随时间的反应性)和信度(稳定性)。
大多数 473 名照顾者为女性(85%)、非西班牙裔白人(61%)和已婚(75%)。用 Ped-PRO-CTCAE [照顾者]和 PROMIS 家长代理量表评估的症状呈强相关性(例如,疼痛的 r 值为 0.78;疲劳的 r 值为 0.78;抑郁的 r 值为 0.83)。Ped-PRO-CTCAE [照顾者]量表的大多数项目平均分可区分 PPS 功能水平以及是否因症状控制而用药的儿童和未用药的儿童。随时间推移,Ped-PRO-CTCAE [照顾者]项目平均分的变化对 GIC 有反应。测试-重测评估发现随时间推移具有中等至高度的一致性(57.8%-93.3%)。
本研究在大量且多样化的照顾者样本中发现了 Ped-PRO-CTCAE [照顾者]测量工具具有较强的聚合和区分效度、已知组有效性、反应性和稳定性的有力证据。照顾者的观点为正在接受癌症治疗的儿童和青少年的体验提供了有价值且独特的见解。